Table 1.
Peptide (Abbreviated) | Peptide (Full) | Domain | Am in o Acids | Intracellular Half-Life (Days) | N | Extracellular Half-Life (Days) | N | ||
---|---|---|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | ||||||
QEFE | QEFEVMEDHAGTYGLGDR | N term | 6–23 | 6.44 | 0.32 | 4 | 6.35 | 1.17 | 4 |
DHAGTY | DHAGTYGLG | N term | 13–21 | 6.47 | 0.89 | 2 | 7.50 | 0.79 | 2 |
DQGGYT | DQGGYTMHQDQEGDTDAGLK | N term | 25–44 | 5.09 | 0.36 | 2 | 3.69 | N/A | 1 |
0N | AEEAGIGDTPSLEDEAAGHVTQAR | 0N | 103–126 | 6.81 | 0.67 | 4 | 6.36 | 0.88 | 4 |
DTPSLE | DTPSLE | Mid | 110–115 | 6.32 | 0.65 | 2 | 6.85 | 0.63 | 4 |
TPSL | TPSLPTPPTR | Mid | 212–221 | 7.84 | 0.66 | 4 | 6.77 | 1.49 | 4 |
LQTA | LQTAPVPMPDLK | MTBR-N | 243–254 | 6.45 | 0.71 | 4 | 6.64 | 0.85 | 2 |
IGST | IGSTENLK | MTBR-N | 260–267 | 6.56 | 0.67 | 4 | 6.99 | 0.62 | 2 |
LDL 4R | LDLSNVQSK | 4R | 282–290 | 3.57 | 0.20 | 2 | N/A | N/A | 0 |
HVPGG 4R | HVPGGGSVQIVYK | 4R | 299–311 | 4.34 | 0.37 | 2 | N/A | N/A | 0 |
3R | VQIVYKPVDLSK | 3R | 306–317 | 6.98 | 0.72 | 4 | 7.34 | 0.94 | 4 |
DRVQSK | DRVQSKIGSL | MTBR-C | 348–357 | 6.08 | 1.16 | 2 | 4.24 | 1.77 | 2 |
IGSL | IGSLDNITHVPGGGNK | MTBR-C | 354–369 | 6.38 | 0.97 | 4 | 5.24 | 0.33 | 2 |
DTSPR | DTSPRHLSNVSSTGSI | Cterm | 402–417 | 4.93 | 0.51 | 2 | 2.52 | N/A | 1 |
DSPQL | DSPQLATLA | Cterm | 421–429 | 6.10 | 1.12 | 2 | 5.41 | 0.04 | 2 |
DEVSAS | DEVSASLAKQGL | Cterm | 430–441 | 4.75 | 0.96 | 2 | 3.33 | 0.42 | 2 |
Mean all | 5.95 | 1.11 | 5.68 | 1.62 | |||||
Mean N term to MTBR-N (without DQGGY) | 6.70 | 0.53 | 6.78 | 0.40 | |||||
Mean MTBR-C | 6.23 | 0.21 | 4.74 | 0.70 | |||||
Mean C term | 5.26 | 0.73 | 3.75 | 1.49 |
N/A, not available due to limit of detection; MTBR, microtubule-binding region; SD, standard deviation; N represents number of cell lines analyzed.